Deals, Development and Manufacturing

PPD and Pfizer Enter into Three-Year Agreement

August 04, 2020

PPD announced it will provide drug development services to advance Pfizer’s portfolio.

Vico Therapeutics Raises $31 Million in Series A Financing Round

July 30, 2020

Vico Therapeutics has raised $31 million (€27 million) in a Series A financing round, which the company will use to further advance its Antisense OligoNucleotides lead platform.

Intravacc and Celonic Partner for COVID-19 Vaccine Development

July 30, 2020

The companies will combine Intravacc’s OMV delivery platform with S-proteins with Celonic’s CHOvolution mammalian cell expression system to produce B and T-cell responses against SARS-CoV-2.

LGM Pharma Acquires Nexgen

July 30, 2020

The acquisition gives LGM access to Nexgen’s manufacturing and warehouse distribution facilities and a pilot plant.

Avacta, Daewoong Pharmaceutical Expand Collaboration to Include COVID-19 Therapy

July 30, 2020

Avacta Group has expanded its partnership with Daewoong Pharmaceutical to include Affimer molecules that target viruses, such as coronavirus.

Avid and Argonaut Enter into Manufacturing Solutions Co-Marketing Agreement

July 30, 2020

The companies will utilize Avid’s upstream and downstream process development and drug substance manufacturing services in conjunction with Argonaut’s parenteral drug product fill-finish services for the delivery of CGMP parenteral drug products for use in clinical studies.

Novartis and Sangamo Announce Gene Therapy Collaboration for up to $795 Million

July 30, 2020

Sangamo will receive a $75 million upfront license fee payment and will be eligible to earn up to $720 million in other development and commercial milestone payments, including up to $420 million in development milestones and up to $300 million in commercial milestones.

Cerevel Therapeutics Enters into $445 Million Deal with Arya Sciences

July 30, 2020

The transaction is expected to be completed during the fourth quarter of 2020.

Sterling Pharma Signs Agreement to Support COVID-19 Treatment Development

July 29, 2020

Sterling Pharma Solutions has signed a deal with Moleculin Biotech to support the development of WP1122, a potential COVID-19 treatment.

DuPont and Rutgers University Enter Research Collaboration

July 29, 2020

DuPont Nutrition and Biosciences has entered into a research collaboration in microbiome science with the Center for Advanced Biotechnology and Medicine at Rutgers University.